Create a free research account to view current pricing and place an order.
Mechanism of action
DSIP is a sleep-associated neuropeptide researched for sleep architecture, stress-response modulation, and neuroendocrine rhythm effects. Human response appears highly individualized.
Half-life & pharmacokinetics
Half-life: Short acting.
Human pharmacokinetics are not standardized. Treat exposure as short acting unless compound-specific data or formal formulation labeling indicates otherwise.
Research dosing reference
100-500 mcg at bedtime or sleep-protocol timing.
Dose interpretation (U-100 units)
| Target dose | U-100 units |
|---|---|
| 100 mcg | 4 units |
| 250 mcg | 10 units |
| 500 mcg | 20 units |
Units are concentration-specific - confirm against your actual reconstitution volume.
Reconstitution & concentration
| Vial | Preferred reconstitution | Final concentration |
|---|---|---|
| 5 mg | 2 mL BAC Water | 0.025 mg/unit |
Injection timing
Evening or bedtime research timing is typical; avoid first exposure before an important sleep/work cycle.
Beginner escalation
Start low because sedation, stimulation, or lack of response can be individualized.
Side-effect mitigation
Monitor vivid dreams, morning grogginess, paradoxical stimulation, headache, or sleep disruption.
Stack compatibility
Pairs cautiously with sleep protocols; avoid combining with multiple sedating or neuroactive agents initially.
Storage & stability
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically.
Protocol duration & reassessment
Sleep-focused protocols should be reassessed after 1-3 weeks. Continue only if sleep quality improves without next-day impairment or paradoxical stimulation.
Frequently asked questions
What is DSIP and how does it work?
DSIP is a sleep-associated neuropeptide researched for sleep architecture, stress-response modulation, and neuroendocrine rhythm effects. Human response appears highly individualized.
What is the half-life of DSIP?
DSIP: Short acting. Human pharmacokinetics are not standardized. Treat exposure as short acting unless compound-specific data or formal formulation labeling indicates otherwise.
How is DSIP reconstituted for research?
Preferred reconstitution for the 5 mg vial is 2 mL BAC Water, giving 0.025 mg/unit. Always confirm concentration math before any use. Research use only.
Is DSIP FDA approved?
No. DSIP is an investigational research-use-only compound - not for human or animal consumption and not FDA approved.
DSIP product overview · DSIP cost · All research reference · Research guides
External references: Peptide (Wikipedia) · U.S. Food and Drug Administration